Abstract:OBJECTIVE:To study the preparation of diagnostic gene chip for detecting hepatitis B virus (HBV) and hepatitis C virus (HCV) and its accuracy in detecting HBV DNA and HCV RNA in serum and liver tissues.METHODS:The probes, which depend on the conservative gene fragment of hepatitis virus, was designed, synthesized and spotted on the modified glass. The probes and some other control probes were assembled on the diagnostic microarray of hepatitis virus. The gene of hepatitis virus, purified from blood or tissue, was labeled with fluorescence and hybridized to the microarray. The hybridized microarry was scanned with microarray scanner and the diagnostic result was analyzed from the scanning data. Fourty patients with hepatitis B virus and 40 healthy people or 40 patients with hepatitis C virus were subjected to detection of HBV DNA and HCV RNA with the hepatitis virus gene chip by the double-blind method. Paraffin liver specimens obtained from 99 cases of posthepatitic cirrhosis were used to detect HBV DNA. The liver tissues and serum from 15 cases of chronic hepatitis B were used to detect HBV DNA. Simultaneously, HBsAg and HBcAg were detected in the serum by fluorescence microparticle quantitation, HBV DNA and HCV RNA in the serum by PCR, and HBcAg in liver tissues by immunocytochemistry or HBV DNA by in situ molecular hybridization.RESULTS:Chip detection of serum specimens showed that 30 patients were HBV DNA positive and 10 HBV DNA negative in the 40 patients with HBV positive, 25 patients were HCV RNA positive and 15 patients were HCV RNA negative in the 40 patients with HCV positive, and all were HBV and HCV negative in the 40 healthy people. In 15 patients with HBV marker positive who were subjected to liver biopsy, 15 patients were detected HBV DNA positive in serum by gene chip, 15 patients HBcAg positive in liver tissues by immunocytochemistry, 14 patients HBV DNA positive in liver tissues by in situ molecular hybridization, and 14 patients HBV DNA positive in liver tissues by gene chip. Paraffin liver tissues specimens from the 99 patients with posthepatitis B cirrhosis showed that 67 patients were detected HBcAg positive by immunocytochemistry, 53 patients HBV DNA positive by in situ molecular hybridization, and 46 patients HBV DNA positive by gene chip. In the 46 patients, 40 patients were detected HBV DNA and HBcAg positive by in situ molecular hybridization and immunocytochemistry, 6 patients only HBcAg positive, and 33 patients HBcAg negative.CONCLUSIONS:The designed diagnostic gene chip can be used to simultaneously detect serum HBV DNA and HCV RNA, but the positive rate of HCV RNA diagnosed by this chip is lower. The gene chip can detect HBV DNA in serum and in liver tissue.

DETECTION OF GENE MUTATIONS IN HBV PRECORE AND BASIC CORE PROMOTER REGION USING MICROARRAY TECHNIQUE

The Clinical Study on the Detecting Simultaneity HBV DNA in the Serum and Liver Tissuse of Patients with DNA Microarry Technique

Hepatitis Gene Chip in Detecting HBV DNA, HCV RNA in Serum and Liver Tissue Samples of Hepatitis Patients.

Detecting of the Hepatic Fibrotic Indexes and Serous Markers from Patients with Chronic Hepatitis B (chb)and Variation of HBV DNA YMDD

Development and application of a mixed microarray in detection of genes of HBV and HCV

Microarrays for Detecting HBV and HDV

Development of Diagnostic Microarray in Detection of HBV and HCV

Mutations in Precore and Core Promoter Region of HBV in Patients with Hepatic Failure.

[Establishment and Preliminary Application of a Gene Chip for Detection of Hepatitis B Virus "a" Determinant Hotpoint Mutation].

[Study of gene chips in the detection of YMDD mutations in the region of HBV polymeras]

Detection and Identification of Emergence of HBV YMDD Motif Mutation During Lamivudine Treatment by Hybridization to an Oligonucleotide Array

Evaluation of the Performance of a DNA Microarray Method for Detecting HBV Mutations Conferring Antiviral Resistance to Lamivudine and Adefovir

Development and application of a reverse hybridization method for detection of hepatitis B virus precore mutation associated with hepatocellular carcinoma

The Clinical Value of Using Gene Arrays to Detect HBV Multi-locus Variant and Gene Typing

Mutation of Hepatitis B Virus Precore/basal Core Promoter in 234 Patients with Chronic Hepatitis

The Clinical Application of Detection Drug-Resistant Mutational Site and HBV Genotype

Detection of A1762T/G1764A mutations in the basic core promoter of hepatitis B virus by reverse dot blot hybridization

Correlation between hot spot mutation in HBV PreC/C, BCP and disease progress

Analysis of HBV Precore 1896 Site Mutation and Its HBV Genotype and Other Laboratory Features

Association of hepatitis B virus mutations in basal core promoter and precore regions with severity of liver disease: an investigation of 793 Chinese patients with mild and severe chronic hepatitis B and acute-on-chronic liver failure

In-Situ Mutation Detection by Magnetic Beads-Probe Based on Single Base Extension and Its Application in Genotyping of Hepatitis B Virus Pre-C Region 1896nt Locus Single Nucleotide Polymorphisms.